When applying the biomarker cut-offs that allowed for approximately 90% diagnostic sensitivity for PCa, the diagnostic specificity of PHID (32.7%) was higher than that of PHI (30.0%), PSAD (22.7%), and PSA (6.8%). The gene discussed is KLK3; the disease is posterior cortical atrophy.